A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

10.2K views

DOI:

10.3791/57231

September 10th, 2018

* These authors contributed equally

In This Article

Summary

This method describes the placement of interposition vein grafts in rabbits, the transduction of the grafts, and the achievement of durable transgene expression. This allows the investigation of physiological and pathological roles of transgenes and their protein products in grafted veins, and testing of gene therapies for vein graft disease.

Abstract

Vein graft bypass surgery is a common treatment for occlusive arterial disease; however, long-term success is limited by graft failure due to thrombosis, intimal hyperplasia, and atherosclerosis. The goal of this article is to demonstrate a method for placing bilateral venous interposition grafts in a rabbit, then transducing the grafts with a gene transfer vector that achieves durable transgene expression. The method allows the investigation of the biological roles of genes and their protein products in normal vein graft homeostasis. It also allows the testing of transgenes for the activities that could prevent vein graft failure, e.g., whether the expression of a transgene prevents the neointimal growth, reduces the vascular inflammation, or reduces atherosclerosis in rabbits fed with a high-fat diet. During an initial survival surgery, the segments of right and left external jugular vein are excised and placed bilaterally as reversed end-to-side common carotid artery interposition grafts. During a second survival surgery, performed 28 days later, each of the grafts is isolated from the circulation with vascular clips and the lumens are filled (via an arteriotomy) with a solution containing a helper-dependent adenoviral (HDAd) vector. After a 20-min incubation, the vector solution is aspirated, the arteriotomy is repaired, and flow is restored. The veins are harvested at time points dictated by individual experimental protocols. The 28-day delay between the graft placement and the transduction is necessary to ensure the adaptation of the vein graft to the arterial circulation. This adaptation avoids rapid loss of transgene expression that occurs in vein grafts transduced before or immediately after grafting. The method is unique in its ability to achieve durable, stable transgene expression in grafted veins. Compared to other large animal vein graft models, rabbits have advantages of low cost and easy handling. Compared to rodent vein graft models, rabbits have larger and easier-to-manipulate blood vessels that provide abundant tissue for analysis.

Introduction

Atherosclerosis is a chronic inflammatory disease in which lipid accumulation and inflammation in the blood vessel wall lead to narrowing of the vessel lumen, heart attacks, strokes, and loss of limbs1,2. Percutaneous interventions (e.g., angioplasty and stenting) and medical therapy (e.g., statins and antiplatelet agents) are useful treatments for atherosclerosis; however, they are often ineffective in treating severe obstructive disease both in the coronary and peripheral circulations. Bypass grafting, using autogenous vein segments, remains a common procedure for treating patients with sev....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal protocols and studies were approved by the University of Washington Office of Animal Welfare.

1. Pre-operation (for All Surgeries)

  1. Anesthetize the rabbit with 30 mg/kg ketamine and 1.5 mg/kg xylazine by intramuscular injection (IM) in the paraspinous muscles.
    ​NOTE: Food and water are not restricted before surgery.
  2. While waiting for sufficient depth of anesthesia, set up the tables in the preparation room and operating room (OR).
    1. Prepare the preparation room for shaving the rabbit's neck and the placement of the intravenous (IV) port in the ear (survival surgery only). Place the ....

Access restricted. Please log in or start a trial to view this content.

Results

The technical proficiency of a new operator must be validated before the operator can use this method to generate experimental data. The first milestone that a new operator must achieve is consistent vein graft patency after both the initial vein-grafting surgery and the subsequent delayed-transduction surgery. Over 90% patency after each of the surgeries is desirable and achievable. The patency can be assessed non-invasively using transcutaneous ultrasound, which we typically perform on .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Critical steps in this protocol include the management of anesthesia, anticoagulation, surgical manipulation of the artery/grafted vein, and hemodynamic measurements of the grafted vein. Proper management of anesthesia is critical in this multiple survival surgery model that includes two relatively long operations (typically 3-3.5 h for bilateral vein grafting and 1.5-2.5 h for bilateral graft transduction). We have administered anesthesia both via a nosecone and by endotracheal intubation and found that the intubation i.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Disposables
3mL syringe with 24G needleBecton Dickinson3095712x for vein graft surgery; 2x for gene transfer  surgery
1 mL syringe with 27G needleBecton Dickinson3096232x for vein graft surgery, 5x for gene transfer surgery
19G needleBecton Dickinson305187Gene transfer surgery
20 mL syringe, luer lockNipro Medical CorpJD+20L
Catheters, 24Ga x 3/4”Terumo Medical ProductsSROX2419V
21G needleBecton Dickinson305165Gene transfer surgery and for 20 mL syringe of saline
Gauze 4” x 4”Dynarex3242~10-15 per surgery
3-0 silk sutureCovidien Ltd.S-244
5-0 silk sutureCovidien Ltd.S-182
7-0 polypropylene sutureCP Medical8703PVein graft surgery
7-0 polypropylene sutureCP Medical8648PGene transfer surgery
5-0 polyglycolic acid sutureCP Medical421A
3-0 polyglycolic acid sutureCP Medical398A
Alcohol swabsCovidien Ltd.6818For the placement of I.V. line
Catheter plugVetoquinol411498
Ketamine HCl, 100 mg/mLVedco Inc.5098916106
Xylazine, 100 mg/mLAkorn Inc.4821
Lidocaine, 20 mg/mLPfizer409427702
Marcaine 0.5%Pfizer409161050
Beuthanasia D-SpecialIntervet Inc.NDC 00061047305Harvest surgery only
Buprenorphine HCl, 0.3 mg/mLPatterson Veterinary12496075705
Saline IV bag, 0.9% sodium chlorideBaxter2B1309
Heparin  (5000 U/mL)APP PharmaceuticalsNDC 63323-047-10
Papaverine (3.5 mg/ml)American Reagent Inc.NDC 0517-4002-25Diluted from 30mg/mL stock; Use 1 mL maximum
Fentanyl patch, 25 mcg/hApotex Corp.NDC 60505-7006-2
IsofluraneMultiple vendorsCatalog number not available
 Viral vectorGene transfer surgery only
Surgical Instruments
Metzenbaum needle holder 7" straightRobozRS-7900
Operating scissors 6.5" straight blunt/bluntRobozRS-6828
Needle holder /w suture scissorsMiltex8-14-IMC
Castroviejo scissorsRobozRS-5658
Castroviejo needle holder, 5.75" straight with lockRobozRS-6412
Stevens scissors 4.25" curved blunt/bluntRobozRS-5943
Alm retractor 4" 4X4 5mm blunt prongsRobozRS-65142x
Backhaus towel clamp 3.5"Roboz4x
Micro clip setting forceps 4.75"RobozRS-6496
Micro vascular clips, 11 mmRoboz
Surg-I-LoopScanlan International1001-81M5 cm length
Bonaccolto forceps, 4” (10 cm) long longitudinal serrations, cross serrated tip, 1.2mm tip widthRobozRS-5210
Dumont #3 forceps Inox tip size .17 × .10 mmRobozRS-5042
Graefe forceps, 4” (10 cm) long serrated straight, 0.8 mm tipRobozRS-5280
Halstead mosquito forceps,  5" straight, 1.3 mm tipsRobozRS-71102x
Halstead mosquito forceps,  5" curved, 1.3mm tipsRobozRS-7111
Jacobson mosquito forceps 5" curved extra delicate, 0.9 mm tipsRobozRS-7117
Kantrowitz forceps, 7.25" 90 degree delicate, 1.7 mm tipsRobozRS-7305
Tissue forceps 5", 1X2 teeth, 2 mm tip widthRobozRS-8162
Allis-Baby forceps, 12 cm, 4x5 teeth, 3 mm tip widthFine Science Tools11092-122x
Adson forceps, 12 cm, serrated, straightFine Science Tools11006-12
Veterinary electrosurgery handpiece and electrodeMACAN ManufacturingHPAC-1; R-F11
Surgical Suite Equipment
Circulating warm water blanket and pumpMultiple vendorsCatalog number not available
Bair hugger warming unit3MModel 505
IV infusion pumpHeskaVet IV 2.2
Isoflurane vaporizer and scavengerMultiple vendorsCatalog number not available
Veterinary multi-parameter monitorSurgivetSurgivet Advisor
Veterinary electrosurgery unitMACAN ManufacturingMV-9
Surgical microscopeD.F. VasconcellosM90025X magnification for vein graft surgery; 16X magnification for gene transfer surgery

References

  1. Libby, P., Bornfeldt, K. E., Tall, A. R. Atherosclerosis: Successes, Surprises, and Future Challenges. Circ Res. 118, 531-534 (2016).
  2. Fowkes, F. G., et al. Comparison of global estimates of prevalence and ris....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Vein GraftGene TransferAdenoviral VectorVascular SurgeryGraft PatencyArteriotomy Repair